Satsuma Pharmaceuticals Inc (NASDAQ:STSA) announced favorable safety, tolerability, and efficacy results from its recent analysis of the ongoing STS101 ASCEND…
United Therapeutics Corp (NASDAQ:UTHR) has terminated the Phase 3 PERFECT study evaluating Tyvaso (treprostinil) Inhalation Solution for pulmonary hypertension associated with…
Repligen Corporation (NASDAQ:RGEN) entered into a strategic partnership and exclusive license agreement with DRS Daylight Solutions to expand the use of…
The European Commission has approved AstraZeneca plc’s (NASDAQ:AZN) Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination as COVID-19 treatment…